Loading company financials…
NEW YORK STOCK EXCHANGE, INC. · Insurance · CIK 0000004977
$123.27
+2.60% · delayed ~15 min
Last price from Oct 22, 2026
$63.94B market value
From AFLAC INC's FY2025 10-K, filed Feb 25, 2026 · read the filing
AFLAC sells insurance. It took in $17.16B last year, which makes it a large company. Of every dollar it sells, about 21 cents is left as profit.
The financial picture is led by profitability, with debt worth watching, while growth remain weak.
A conclusion from the filings, not a recommendation. Detailed figures and supporting evidence appear in their dedicated sections below.
Financial health
A mixed picture — some clear strengths and some weaknesses.
From AFLAC INC's FY2025 annual filing · share price scored separately
Largest year-over-year changes in FY2025
Profit
$5.44B → $3.65B
Profit margin
28.8% → 21.2%
Earnings per share
$9.90 → $7.03
Shares in issue
550.0M → 518.7M
Measured against FY2024, from the 10-K filed Feb 25, 2026
Deteriorated: -33.0%
$5.44B to $3.65BSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
How the latest move compares (quote delayed ~15 min), and what was published around it
AFL rose 2.60% on the latest quote. The average Financials company tracked here moved +1.09%, and the S&P 500 −1.04%. That is 1.5 points above its sector and 3.6 points above the market.
Expectations
Not from the filings — what other people are betting on, and what the price already assumes.
Opinions from 24 analysts covering this company, as of . Their views, not this site's.
Of 24 analysts publishing on this company, 1 say strong buy, 2 say buy, 12 say hold, 7 say sell and 2 say strong sell. Analysts are paid to publish a view and are wrong often; the split above says how much they agree with each other, which is the part a single headline rating hides.
The essentials
Each answered from the filings, with the numbers behind it.
Yes. It keeps about 21 cents of every dollar of sales as profit, earning $3.65B last year.
No. Sales shrank 9.3% last year.
For every $1 it owes, it owns $1.34 in assets. Banks and insurers always carry high debt — that is how lending works — so this is normal for the industry and not comparable with other sectors.
Core operating and valuation reference metrics
Whether the dividend is covered by what the business actually earns
It pays out 33 cents of every dollar of profit and keeps the rest, which leaves the payment comfortably covered. It paid out 47% of the cash its operations generated. It has paid in each of the last 12 years.
GoodNext payment expected around , projected from how regularly it has paid before rather than from a date the company has announced.
Figures from the FY2025 annual filing
Last year it earned $3.65B and generated $2.56B of cash from operations.
As reported to the SEC, in USD. Hover or show sources to see where each figure came from.
| Income statement | FY202510-K · Feb 25, 2026Filing for FY2025 | FY202410-K · Feb 26, 2025Filing for FY2024 | FY202310-K · Feb 22, 2024Filing for FY2023 | FY202210-K · Feb 22, 2024Filing for FY2022 | FY202110-K · Feb 22, 2024Filing for FY2021 | ChangeFY2025 vs FY2024 |
|---|---|---|---|---|---|---|
| RevenueWhat is this? | $17.16B | $18.93B | $18.70B | $19.14B | $21.55B | −9.3% |
| Selling, general and administrative | $3.25B | $3.01B | $3.17B | $3.25B | $3.54B | +7.9% |
| Operating income | — | — | — | $4.16B | $4.93B | — |
| Operating marginOperating income ÷ revenueWhat is this? | — | — | — | 21.7% | 22.9% | — |
| Interest expense | $217.0M | $194.0M | $195.0M | $226.0M | $238.0M | +11.9% |
| Income before tax | $4.53B | $6.42B | $5.26B | $4.87B | $5.21B | −29.4% |
| Net income | $3.65B | $5.44B | $4.66B | $4.42B | $4.23B | −33.0% |
| Net marginNet income ÷ revenueWhat is this? | 21.2% | 28.8% | 24.9% | 23.1% | 19.6% | −7.5 pts |
| Earnings per shareNet income ÷ shares outstanding at the period end — close to, but not the same as, the reported EPSWhat is this? | $7.03 | $9.90 | $8.05 | $7.18 | $6.49 | −29.0% |
† calculated from other reported figures, such as total liabilities as assets minus equity.
This company's latest filing beside its peers' stored scores
| Company | Health | F-Score | Revenue growth | Profit margin | P/E | Debt to equity |
|---|---|---|---|---|---|---|
| AFLAFLAC INC · this page | 6.0/10 | 3/6 |
Insider activity, ownership stakes and what's coming — straight from EDGAR, before any article is written about it
Officers, directors and major shareholders must report within two business days of a trade.
Sold on the open market — 88,114 shares at $118.19 ($10.4M)
Holds 50,159,826 shares after this filing.
20 recent filings, newest first. Each is labelled from its form and item numbers, not from its wording.
Quarterly report for Q2 FY2026
Profit margin +5.6 pts · Earnings per share +46.7% · Profit +37.7% — against Q2 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingWrite down why you are following AFLAC INC, what has to go right and what would change your mind, then see each new annual report measured against it. Sign in to start one.
Go deeper
Every figure above traces back to a filing in the timeline, each linked to the document itself.
The 75 subsidiaries named in its 10-K, incorporated across 10 places. A filer lists the significant ones and may leave the rest out, so this is the floor rather than the full count.
Every company's figures are checked for internal consistency: the balance sheet adding up, figures sharing one currency, cash flow and share counts within plausible ranges, and how recent the latest annual report is. Nothing here changes a figure.
Financial figures are from AFL's 10-K for fiscal year 2025 (period ending 2025-12-31, filed Feb 25, 2026), reported under the US GAAP taxonomy. View the source filing.
3 of 4 scored areas had enough reported figures to judge
The score averages profitability, growth, debt and accounting. Accounting had too few reported figures and is left out of the average rather than counted as a weakness, so a company is never marked down for a figure it did not publish. Cash generation is shown for context and already feeds profitability. Valuation is scored separately, because a share price says nothing about whether the business is sound. 6 of the 9 Piotroski checks could be evaluated. How the score works
Each year scored only from its annual report as it was first filed
| Fiscal year | Health | F-Score | Scored from |
|---|---|---|---|
| FY2025 | 6.0 | 3/6 | 10-K, filed Feb 25, 2026 |
| FY2024 | 7.3 | 5/6 | 10-K, filed Feb 26, 2025 |
| FY2023 | 6.0 | 5/6 | 10-K, filed Feb 22, 2024 |
| FY2022 | 6.0 | 5/6 | 10-K, filed Feb 22, 2024 |
| FY2021 | 6.0 | 5/6 | 10-K, filed Feb 23, 2022 |
| FY2020 | 6.0 | 5/6 | 10-K, filed Feb 23, 2021 |
A later restatement never reaches back into an earlier year, and every year is scored without a share price, so the latest point can differ a little from the headline score, which uses today's price.
Every check behind the three models, and what each one tests
3 of 6 checks passed
Nine yes-or-no tests of whether this year's finances improved on last year's. 3 could not be evaluated and are excluded from the total rather than counted as failures.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Distance from bankruptcy, from a model fitted on companies that did and did not go bust. It describes a balance sheet's shape today; it does not forecast a failure.
not reported — Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Screens eight accounting ratios for the pattern earnings manipulators tend to leave. A flag is a reason to read the filing closely, never evidence of wrongdoing.
Every figure above comes from the FY2025 filing as filed with the SEC.
Deteriorated: −7.5 pts
28.8% to 21.2%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -29.0%
$9.90 to $7.03Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: -5.7%
550.0M to 518.7MSignificant
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Deteriorated: -9.3%
$18.93B to $17.16BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Changed: +10.2%
$1.09B to $1.20BNotable
Why it matters: Cash handed to shareholders. A rise can be a higher dividend or simply more shares, and a cut is a decision the company explains in its own filing — neither is rated here.
Q2 FY2026 against Q2 FY2025, from the 10-Q filed Aug 7, 2026 — read it.
Improved: +46.7%
$1.12 to $1.64Critical
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Improved: +37.7%
$599.0M to $825.0MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Improved: +5.6 pts
14.4% to 20.0%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Improved: -6.1%
534.8M to 502.3MSignificant
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
Deteriorated: -12.1%
$6.96B to $6.12BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Q2 FY2026 against Q1 FY2026, from the 10-Q filed Aug 7, 2026 — read it. Quarter-to-quarter moves include seasonal swings — a retailer's holiday quarter — which the year-earlier comparison removes.
Deteriorated: -19.0%
$1.02B to $825.0MSignificant
Why it matters: Profit swings far more than sales do, and one-off items — a legal settlement, a tax charge, an asset sale — move it without the underlying business changing.
Deteriorated: −3.4 pts
23.4% to 20.0%Significant
Why it matters: What survives to the very end of each sale. Worth reading beside revenue: growing sales on a shrinking margin means the company is buying its growth.
Deteriorated: -17.7%
$2.00 to $1.64Significant
Why it matters: Profit divided by the shares in issue at the period end, so it sits close to but not on the company's own reported figure. It can rise with no growth in profit when the company buys back stock — read it beside the share count.
Deteriorated: -5.3%
$4.35B to $4.12BNotable
Why it matters: Sales are what everything else is built on. A fall can be lost customers, lower prices, or a business the company sold — the filing itself says which.
Improved: +8.2%
$5.65B to $6.12BNotable
Why it matters: A falling cash pile is only a warning if the company is consuming it. Paying down debt, buying back stock and paying a dividend all reduce cash by choice.
Improved: -1.6%
510.5M to 502.3MNotable
Why it matters: The company bought back stock, so each remaining holding owns slightly more of it. Worth checking it was not funded by borrowing.
1 other measure barely moved. Figures compare the two most recent annual filings — read the latest one. Moves are graded on fixed lines — 5%, 15% and 40% for amounts, and 1, 3 and 8 points for margins — as notable, significant or critical. Nothing here reads the management commentary, which is where a company explains its own numbers.
These coincide with the move in time. None is presented as its cause: a price can move on news that names no company, on the wider market, or on trading that no document records.
Filter by minute, hour, day or week — or compare against peers
Loading price history…
Published by Finnhub. Analyst coverage skews towards larger companies and towards optimism — sell ratings are rare across the whole market, so a company with none is ordinary rather than endorsed.
Measured on and published about a week later — this is a fortnightly snapshot, not a live position.
About 2.2% of this company's shares have been borrowed and sold by people expecting to buy them back cheaper. That is a bet the price falls. Those people can be wrong, and when a heavily shorted share rises they have to buy it back, which pushes it up further.
Collected by FINRA from broker-dealers twice a month. It counts positions, not intentions, and some of it is hedging rather than a directional bet against the company.
Nothing in this section is a figure this company reported about itself. These are expectations and positions — what the price implies, what analysts have published, what short sellers are betting, and what large funds held at the last count. WylthIQ reports them; it does not endorse them, does not forecast prices, and takes no view on whether any of them will turn out to be right.
The trailing P/E is 15.7x — investors pay $15.7 for each $1 of trailing profit.
Not meaningful for banks, insurers and other financial companies. Their balance sheets have no working capital and are leveraged by design, which this model misreads as distress.
Reported annual figures
| -9.3% |
| 21.2% |
| 17.54x |
| 2.95x |
| METMETLIFE INC | 6.0/10 | 4/6 | 8.5% | 138.7% | 20.09x | 25.22x |
|---|
| PRUPRUDENTIAL FINANCIAL INC | 3.3/10 | 6/7 | -13.7% | 5.9% | 11.70x | 22.76x |
|---|
| PFGPRINCIPAL FINANCIAL GROUP INC | 3.3/10 | 5/7 | -3.1% | 7.6% | 20.20x | 27.68x |
|---|
| GLGLOBE LIFE INC. | 7.3/10 | 6/7 | 3.7% | 19.4% | 13.37x | 4.16x |
|---|
| LNCLINCOLN NATIONAL CORP | 3.3/10 | 2/7 | -1.2% | 6.5% | 6.64x | 37.25x |
|---|
| Median of peers | 3.3/10 | — | -1.2% | 7.6% | 13.37x | 25.22x |
|---|
Peers come from the company's industry classification. A difference describes the companies; it does not rank them.
Sold on the open market — 19,122 shares at $119.48 ($2.3M)
Holds 50,140,704 shares after this filing.
Sold on the open market — 6,375 shares at $120.31 ($767.0K)
Holds 50,134,329 shares after this filing.
Sold on the open market — 6,305 shares at $116.55 ($734.8K)
Holds 50,296,635 shares after this filing.
Sold on the open market — 19,046 shares at $117.61 ($2.2M)
Holds 50,277,589 shares after this filing.
Sold on the open market — 29,649 shares at $118.17 ($3.5M)
Holds 50,247,940 shares after this filing.
Sold on the open market — 41,660 shares at $116.37 ($4.8M)
Holds 50,303,280 shares after this filing.
Sold on the open market — 340 shares at $117.03 ($39.8K)
Holds 50,302,940 shares after this filing.
Sold on the open market — 11,468 shares at $115.83 ($1.3M)
Holds 50,345,672 shares after this filing.
Sold on the open market — 732 shares at $116.24 ($85.1K)
Holds 50,344,940 shares after this filing.
Sold on the open market — 11,960 shares at $114.72 ($1.4M)
Holds 50,357,180 shares after this filing.
Sold on the open market — 40 shares at $115.52 ($4.6K)
Holds 50,357,140 shares after this filing.
Sold on the open market — 3,257 shares at $112.95 ($367.9K)
Holds 50,378,883 shares after this filing.
Sold on the open market — 950 shares at $113.81 ($108.1K)
Holds 50,377,933 shares after this filing.
Sold on the open market — 8,393 shares at $115.05 ($965.6K)
Holds 50,369,540 shares after this filing.
Sold on the open market — 400 shares at $115.64 ($46.3K)
Holds 50,369,140 shares after this filing.
Sold on the open market — 11,960 shares at $112.80 ($1.3M)
Holds 50,382,180 shares after this filing.
Sold on the open market — 40 shares at $113.58 ($4.5K)
Holds 50,382,140 shares after this filing.
Sold on the open market — 4,168 shares at $113.23 ($471.9K)
Holds 50,403,022 shares after this filing.
Sold on the open market — 8,882 shares at $113.61 ($1.0M)
Holds 50,394,140 shares after this filing.
Notice filed ahead of a planned sale — the sale itself has not necessarily happened yet.
Filed notice to sell 13,201 shares ($1.6M) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 15,000 shares ($1.8M) on or after .
Shares originally obtained via Restricted Stock Vesting.
Filed notice to sell 600 shares ($74.5K) on or after .
Shares originally obtained via Restricted Stock Vesting.
Estimated from how often this has happened before, not a confirmed date.
Not investment advice, and not a signal to act on by itself — a filing says what happened, not why, and insiders trade for ordinary reasons having nothing to do with where they think the company is headed.
Reported another event
Reported another event
Read the filingReported another event
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2026
Revenue +27.9% · Profit margin +22.6 pts · Profit +3413.8% — against Q1 FY2025
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingProxy statement for a shareholder meeting
Read the filingAnnual report for FY2025
Revenue -9.3% · Profit margin −7.5 pts · Profit -33.0% — against FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingQuarterly report for Q3 FY2025
Revenue +60.7% · Profit margin +37.7 pts · Profit turned positive — against Q3 FY2024
Read the filingPublished results · Made a Regulation FD disclosure
Read the filingTook on a direct financial obligation
Read the filingPublished results
Read the filingQuarterly report for Q2 FY2025
Revenue -19.0% · Profit margin −19.8 pts · Profit -65.9% — against Q2 FY2024
Read the filingReported another event
Read the filingReported another event
Read the filingHeld a shareholder vote
Read the filingQuarterly report for Q1 FY2025
Revenue -37.5% · Profit margin −33.7 pts · Profit -98.5% — against Q1 FY2024
Read the filingThe first 40 of 75. The rest are in the exhibit.
Source: Exhibit 21 of the 10-K filed 2026-02-25. These are legal entities, not brands or acquisitions — a company that bought a business may hold it inside an entity named here, or inside one small enough that the rule does not require naming it at all.
Coverage from the last 30 days
The Wellness Paradox: Why Americans Are Investing in Wellness While Delaying Routine Healthcare
Yahoo ·
Beloved Sports Figure Brian Jordan Joins Aflac in Bringing Comfort to Young Patients at St. Louis Children's Hospital
Yahoo ·
3 Insurance Dividend Stocks That Could Pay You More Every Year in Retirement
Yahoo ·
$11,033 in Annual Dividends: What You Keep in a Roth IRA vs. a Taxable Account
Yahoo ·
Aflac’s Q3 2026 Earnings: What to Expect
Yahoo ·
JP Morgan Maintains Neutral on Aflac, Raises Price Target to $119
Benzinga ·
AM Best Affirms Credit Ratings of Aflac Incorporated and Its Subsidiaries
Yahoo ·
With Loving Hearts and Some Power Tools, Aflac Employees Build 40 Beds for Local Children Through Partnership With Sleep in Heavenly Peace
Yahoo ·
Burnout, misinformation and financial vulnerability driving critical choices across American workforce, with Gen Z at the epicenter
Yahoo ·
Wells Fargo Maintains Equal-Weight on Aflac, Lowers Price Target to $116
Benzinga ·
Keefe, Bruyette & Woods Maintains Market Perform on Aflac, Lowers Price Target to $120
Benzinga ·
Can Unum Group's Colonial Life Sustain Its Earnings Momentum?
Yahoo ·
Primary sources and further research